Dynamic Technology Lab’s VYNE Therapeutics VYNE Stock Holding History

Dynamic Technology Lab’s Portfolio VYNE Stock Details VYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-152	Closed	-$18K	–	1387
2020 Q3	$18K	Buy	+152	New	+$17.7K	﹤0.01%	940

Other funds holding VYNE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Dynamic Technology Lab's VYNE Position: Q4 2020 in Review

Dynamic Technology Lab sold out of VYNE Therapeutics (VYNE) in Q4 2020, closing a stake of 152 shares — an estimated $18K sold.

Dynamic Technology Lab first reported a position in VYNE in Q3 2020 and held it in 1 quarter. The position peaked at $18K in Q3 2020. 104 funds tracked by Wall St. Rank hold VYNE as of Q4 2020.

Dynamic Technology Lab reported no remaining VYNE Therapeutics position as of Q4 2020 after selling out during the quarter.
Dynamic Technology Lab sold 152 VYNE Therapeutics shares in Q4 2020, an estimated $18K.
Dynamic Technology Lab first reported a position in VYNE Therapeutics in Q3 2020 and held it in 1 quarter.
Dynamic Technology Lab's VYNE Therapeutics position peaked at $18K in Q3 2020.
104 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q4 2020.

Based on Dynamic Technology Lab's 13F filing for Q4 2020, filed 11 Feb 2021.